Opioid Overdose: Are Vaccines the Answer?
Opioid overdose vaccines in development could save lives.
Advancements in Cancer Vaccines
Cancer vaccines are proving to be a pillar of personalized treatment.
Early Vaccine Development: The Challenging Case of the West Nile Virus
While there are many vaccines, not every promising vaccine has progressed to market, such as the vaccine for West Nile virus.
Flu Vaccine, Even with Infection, Reduces Risk of Heart Attack and Stroke
The Statens Serum Institut in Copenhagen found that flu vaccines may protect against heart attack and stroke, even if the flu is still developed after vaccination.
Responding to the Opioid Crisis
Opioid vaccines are being developed to save lives.
Preparing for RSV Season with Vaccinations
Respiratory syncytial virus (RSV) can be especially serious for infants and older adults, but vaccines can help reduce the burden on at-risk populations.
FDA Approves Moderna’s mRNA Influenza Vaccine
The U.S. Food and Drug Administration’s accines and Related Biological Products Advisory Committee voted to recommend approval of the Moderna’s investigational mRNA influenza vaccine, which will be marketed under the brand name mFlusiva, for the prevention of flu in adults age 50 to 64.
COVID-19 and Influenza Coadministered Vaccines May Loiwer Risk of MACE in Older Adults
According to a recent study, coadministration of the COVID-19 vaccine with the annual influenza vaccine may reduce COVID-19-related major adverse cardiovascular events (MACE) among older adults, especially those with comorbidities. In the study, researchers conducted a target trial emulation using electronic health record data of more than one million veterans (mean age, 70 years; 92 […]
COVID-19 Vaccines Lower Risk of Heart Attack and Cardiac Death
ccording to three different studies, COVID-19 vaccines were associated with a lower risk of major adverse cardiovascular events (MACE), in addition to other outcomes, particularly among older adults.
Shingles Vaccine Reduces Risk of a Dementia Diagnosis
According to a cohort study using target trial emulation, older adults at higher risk for dementia are less likely to have a dementia diagnosis if they received a herpes zoster (shingles) vaccine.